Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07099092 · ClinicalTrials.gov registry record · Early Phase 1

Causal Mechanisms of Odor-Guided Behavior in Humans

A Early Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).

Not yet
Registry status
Early Phase 1
Development phase
80
Enrollment target

NCT07099092 is a Early Phase 1 study that has not yet begun recruiting, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07099092, a Early Phase 1 study, has not yet begun recruiting, sponsored by National Institute on Drug Abuse (NIDA).

NOT YET RECRUITING
Registry status
Early Phase 1
Development phase
80 participants
Enrollment target

Study Summary

Background: Little is known about how different regions of the brain responsible for the human sense of smell guide behaviors. In this study, researchers use a technique called transcranial ultrasound stimulation (TUS) to learn how odors affect the brain and behavior. Objective: To learn more about how the human sense of smell works. Eligibility: Healthy people aged 18 to 45 years who are right-handed. Design: Participants can volunteer for up to 2 different experiments. Each experiment requires 5 visits, each about 1 week apart. Food, alcohol, and caffeine may be limited before visits. At the start of each visit, participants will answer questions about their health and how well they slept. Their sense of smell will be assessed. Some visits may include tasks on a computer: While doing these tasks, participants may be asked to smell different odors, look at pictures, and listen to sounds. They will wear devices to track breathing, blood pressure, pulse, and other body responses to the tasks. Some visits may include TUS: TUS uses ultrasound waves to briefly change brain activity. A gel will be applied to the scalp and hair, and a device will be placed against the participant s head. Participants may feel a tapping, pulling, and/or warm sensation on the skin underneath the device. They may also feel a twitch in their face, neck, arm, or leg muscles. Participants will do tasks before and after TUS. Some visits will include functional magnetic resonance imaging (fMRI) scans. fMRI uses magnet and radio waves to capture images of the activity inside the brain. Participants will lie on a table that slides into a tube. They will perform tasks inside the scanner.

Interventions

  • DEVICE TUS PirC
  • DEVICE TUS Amy
  • DEVICE TUS Sham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-07-15
Est. Completion 2035-07-14
Phase Early Phase 1

What the Registry Record Tells You About NCT07099092

The ClinicalTrials.gov registry entry for NCT07099092 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which TUS PirC is the first listed.

NCT07099092 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07099092 about?

NCT07099092 is a clinical study titled "Causal Mechanisms of Odor-Guided Behavior in Humans". Background: Little is known about how different regions of the brain responsible for the human sense of smell guide behaviors. In this study, researchers use a technique called transcranial ultrasound stimulation (TUS) to learn how odors affect the brain and behavior. Objective: To learn more abo...

What is the current status of trial NCT07099092?

This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2026-07-15. Estimated completion is 2035-07-14.

What interventions are being tested in trial NCT07099092?

The interventions under investigation include: TUS PirC (DEVICE), TUS Amy (DEVICE), TUS Sham (DEVICE).

Who is sponsoring clinical trial NCT07099092?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.